Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia
暂无分享,去创建一个
E. Siemers | R. Dean | M. Case | R. Demattos | J. Raskin | B. Willis | K. Sundell | D. Lachno | Lisa Ferguson-Sells | K. Holdridge | R. DeMattos | D. R. Lachno
[1] M. Mintun,et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease , 2018, The New England journal of medicine.
[2] F. Curtin,et al. Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study , 2016, mAbs.
[3] Robert A. Dean,et al. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients , 2016, Alzheimer's & Dementia.
[4] Mike P. Wattjes,et al. Remyelination therapy goes to trial for multiple sclerosis , 2014, Neurology: Neuroimmunology & Neuroinflammation.
[5] R. Bateman,et al. CNS Amyloid-β, Soluble APP-α and -β Kinetics during BACE Inhibition , 2014, The Journal of Neuroscience.
[6] E. Siemers,et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.
[7] John Hardy,et al. Antiamyloid therapy for Alzheimer's disease--are we on the right road? , 2014, The New England journal of medicine.
[8] E. Siemers,et al. Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease , 2012, Alzheimer's & Dementia.
[9] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[10] D. Holtzman,et al. Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's Disease , 2002, Science.
[11] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[12] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[13] H. Vanderstichele,et al. Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab. , 2013, Journal of Alzheimer's disease : JAD.